Galen Signs Exclusive Deal In Europe

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--As part of their continued business development efforts to drive growth in existing and new markets, through licensing, acquisition and partnership, Galen Ltd has announced a significant deal with Australian-based, Medical Developments International (MVP). The long term licensing agreement enables Galen to exclusively market, distribute, and supply MVP’s emergency pain relief product, Penthrox®, throughout the UK and Ireland and signifies an exciting next step in building a specialty products’ portfolio in Europe.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC